Bernhardt L. Trout is a Professor of Chemical Engineering at MIT. He is currently the Director of the Novartis-MIT Center for Continuous Manufacturing and the Co-Chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering.

Professor Trout performed his post-doctoral research at the Max-Planck Institute. His research focuses on molecular engineering, specifically the development and application of both computational and experimental molecular-based methods to engineering pharmaceutical formulations and processes with unprecedented specificity. Since 1999, he has focused on molecular engineering for biopharmaceutical formulation, primarily liquid formulation, but also lyophilized formulation.

A major aspect of Professor Trout’s research focuses on developing both microscopic and macroscopic models to design stable formulations efficiently. In 2007, together with several colleagues from MIT, he set up the Novartis-MIT Center for Continuous Manufacturing, a $65 million partnership with the objective of transforming pharmaceutical manufacturing. In addition to Novartis, he has worked with many other pharmaceutical companies in research or consulting engagements. He has published over 130 papers and currently has eight patent applications submitted.

Professor Trout received his S.B. and S.M. degrees from MIT and his Ph.D. from the University of California at Berkeley.